KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Goodwill (2018 - 2025)

Twist Bioscience (TWST) has disclosed Goodwill for 8 consecutive years, with $82.2 million as the latest value for Q4 2025.

  • Quarterly Goodwill fell 4.21% to $82.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $82.2 million through Dec 2025, down 4.21% year-over-year, with the annual reading at $82.2 million for FY2025, 4.21% down from the prior year.
  • Goodwill for Q4 2025 was $82.2 million at Twist Bioscience, roughly flat from $82.2 million in the prior quarter.
  • The five-year high for Goodwill was $85.8 million in Q2 2022, with the low at $1.1 million in Q1 2021.
  • Average Goodwill over 5 years is $74.6 million, with a median of $85.8 million recorded in 2022.
  • The sharpest move saw Goodwill surged 7428.82% in 2022, then decreased 4.21% in 2025.
  • Over 5 years, Goodwill stood at $84.2 million in 2021, then rose by 1.86% to $85.8 million in 2022, then changed by 0.0% to $85.8 million in 2023, then changed by 0.0% to $85.8 million in 2024, then fell by 4.21% to $82.2 million in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $82.2 million, $82.2 million, and $82.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.